Evidence map›Paper›PMID 32756009›Full record

ArticleAging2020

circIQCH sponges miR-145 to promote breast cancer progression by upregulating DNMT3A expression.

Yuehua Li, Baohong Jiang, Zhengxi He, Hongbo Zhu, Rongfang He, Shanji Fan, Xiaoping Wu, Liming Xie, Xiusheng He

Abstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Potential role ofBiochemistry and biophysics reports · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. miR-26a-5p Suppresses Wnt/Disease markers · 2022
    Article
  11. Article
  12. DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy.Frontiers in cell and developmental biology · 2022
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuehua LiDepartment of Medical Oncology, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Baohong JiangDepartment of Pharmacy, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Zhengxi HeDepartment of Oncology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
Hongbo ZhuDepartment of Medical Oncology, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Rongfang HeDepartment of Pathology, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Shanji FanDepartment of Breast and Thyroid Surgery, The First Affiliated Hospital, University of South China, Hengyang, 421001 Hunan Province, China.
Xiaoping WuDepartment of Medical Oncology, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Liming XieDepartment of Medical Oncology, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Xiusheng HeKey Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Cancer Research Institute, Hengyang Medical College, University of South China, Hengyang 421001, Hunan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a unique type of RNA, circular RNAs (circRNAs) are important regulators of multiple biological processes in the progression of cancer. However, the potential role of most circRNAs in breast cancer lung metastasis is still unknown. In this study, we characterized and further investigated circIQCH (hsa_circ_0104345) by analyzing the circRNA microarray profiling in our previous study. circIQCH was upregulated in breast cancer tissues, especially in the metastatic sites. CCK-8, transwell, wound-healing and mouse xenograft assays were carried out to investigate the functions of circIQCH. Knockdown of circIQCH inhibited breast cancer cell proliferation and migration to lung. Moreover, luciferase reporter assays and RNA immunoprecipitation assays were performed to elucidate the underlying molecular mechanism of circIQCH. The results showed that circIQCH sponges miR-145 and promotes breast cancer progression by upregulating DNMT3A. In summary, our study demonstrated the pivotal role of circIQCH-miR-145-DNMT3A axis in breast cancer growth and metastasis via the mechanism of competing endogenous RNAs. Thus, circIQCH could be a potential therapeutic target for breast cancer.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsBreast NeoplasmsDisease ProgressionDNA Modification MethylasesFemaleMiceMice, Inbred BALB CMicroRNAsRNA, CircularTumor Cells, CulturedUp-RegulationDNA Modification MethylasesDnmt3a1 protein, mouseMicroRNAsMIRN145a microRNA, mouseRNA, Circularbreast cancercircIQCHcircular RNAscompetitive endogenous RNAsDNMT3A

Identifiers

PMID32756009
PMCPMC7467367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.